Progression of Vision Loss in Macular Telangiectasia Type 2
Heeren TF, Clemons T, Scholl HP, Bird AC, Holz FG, Charbel Issa P. Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3905-12.
Categories for Publications
Poor long-term outcome of anti-vascular endothelial growth factor therapy in nonproliferative macular telangiectasia type 2
Kupitz EH, Heeren TF, Holz FG, Charbel Issa P. Retina. 2015 Dec;35(12):2619-26.
Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization
Do DV, Bressler SB, Cassard SD, Gower EW, Tabandeh H, Jefferys JL, Bressler NM. Retina. 2014 Oct;34(10):2063-71.
Macular telangiectasia type 2 (MacTel) in a 34-year-old patient
Nicolai H, Wirix M, Spielberg L, Leys A. BMJ Case Rep. 2014 Sep 23;2014. pii: bcr2014204802.
Choroidal thickness in macular telangiectasia type 2
Chhablani J, Kozak I, Jonnadula GB, Venkata A, Narayanan R, Pappuru RR, Rao PS. Retina. 2014 Sep;34(9):1819-23.
“En face” optical coherence tomography imaging in type 2 idiopathic macular telangiectasia
Wolff B, Basdekidou C, Vasseur V, Sahel JA, Gaudric A, Mauget-Faÿsse M. Retina. 2014 Oct;34(10):2072-8.
Multimodal imaging in type 2 idiopathic macular telangiectasia
Sallo FB, Leung I, Clemons TE, Peto T, Bird AC, Pauleikhoff D. Retina. 2015 Apr;35(4):742-9.
A new CRB1 rat mutation links Müller glial cells to retinal telangiectasia.
Zhao M, Andrieu-Soler C, Kowalczuk L, Paz Cortés M, Berdugo M, Dernigoghossian M, Halili F, Jeanny JC, Goldenberg B, Savoldelli... View Article
A novel clinical sign in macular telangiectasia type 2
Jindal A, Choudhury H, Pathengay A, Flynn HW Jr. Ophthalmic Surg Lasers Imaging Retina. 2015 Jan;46(1):134-6. doi: 10.3928/23258160-20150101-26.
Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography
Spaide RF, Klancnik JM Jr, Cooney MJ. JAMA Ophthalmol. 2015 Jan;133(1):45-50. doi: 10.1001/jamaophthalmol.2014.3616.
